Key Highlights
- CIRO halted trading in MindBio Therapeutics Corp. on the Canadian Securities Exchange.
- The halt applies to all issues under the ticker MBIO, effective 8:00 am ET.
- CIRO listed the reason for the halt as a cease trade order.
Trading in MindBio Therapeutics Corp. (CSE: MBIO) was halted by the Canadian Investment Regulatory Organization (CIRO), according to a CIRO halts/resumptions notice dated Nov. 4, 2026.
CIRO’s notice indicated the halt applies to all issues of the company and took effect at 8:00 am ET. The reason given for the halt was a “Cease Trade Order.”
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
In its notice, CIRO described trading halts as temporary suspensions that can be used to help maintain a fair and orderly market. CIRO is Canada’s national self-regulatory organization overseeing investment dealers and trading activity on Canadian debt and equity marketplaces.
The original press release is available on stockhouse.com
s-9v3_h-10v3_i-11v3
